WCG IRB

What WCG IRB does

WCG Clinical, operating commercially as WCG IRB, is a privately held US-headquartered provider of independent ethical review and clinical trial support services founded in 1967. The company delivers Institutional Review Board (IRB) and Institutional Biosafety Committee (IBC) review services, endpoint adjudication, data monitoring committee management, statistical consulting, diversity and inclusion advisory, and site enablement to pharmaceutical sponsors, biotech firms, medical device developers, contract research organizations (CROs), and research sites across 18 countries. WCG holds AAHRPP accreditation and ISO 9001 certification, and the company states it was the trusted partner for 94% of FDA-approved therapeutic agents in the last five years.

The company's technology backbone is the WCG ClinSphere cloud platform, which integrates AI-powered components including Trial IntelX (AI foresight for trial design), Total Enrollment (SaaS recruitment and retention), Total Feasibility (site selection), and eReview Manager (IRB workflow automation), alongside purpose-built tools such as AIMS for endpoint adjudication, SafetyVigilance for safety letter distribution, eResearch Enterprise and eXpress CTMS, IRBNet, and InvestigatorSpace. These are layered on top of an 80k+ protocol dataset (described as the industry's largest), a 38,000+ clinical trial KMR benchmarking database, and a 220k+ investigator network spanning 130+ countries.

WCG monetizes through a hybrid model combining subscription-based SaaS (ClinSphere modules, Total Training) with professional services billed on multi-year contracts (IRB review, IBC review, adjudication, DMC, site enablement, and consulting). The go-to-market is primarily enterprise field sales with dedicated account representatives, complemented by inside sales consultation requests, an event-driven presence at clinical research conferences, and the 200+ member Avoca Quality Consortium community. Sub-brands include ClinSphere, eReview Manager, InvestigatorSpace, Total Enrollment, Total Feasibility, SafetyVigilance, Total Training, AIMS, IRBNet, and the eResearch CTMS line, while wholly owned subsidiaries encompass The Contract Network (acquisition announced 2026), Dr. Vince Clinical Research, Velos, KMR Group, and Avoca.

Name

WCG IRB

Legal name

WCG Clinical

Website

https://wcgclinical.com

Company type

Private

Founded year

1967

Operating status

Operating

Headcount range

501–1,000 employees

Short description

WCG Clinical (WCG IRB) provides independent IRB and IBC review, endpoint adjudication, data monitoring, and AI-powered clinical trial technology to pharma, biotech, medical device, CRO, and research site clients. Founded in 1967, it supports 94% of recent FDA-approved therapeutics.

Ownership category

akta.pro rank

Product category

Clinical Research Services

NAICS

Scientific Research and Development Services (5417), Other Scientific and Technical Consulting Services (54169), Computer Systems Design and Related Services (54151)

SIC

Services-Commercial Physical & Biological Research (8731), Services-Facilities Support Management Services (8744)

akta.pro primary industry

Clinical Research Ethics & Human Subjects Protection Authorities (IRB/REC Oversight) (HLAJACAG)

akta.pro secondary industry

Clinical Operations & Monitoring FSP (CRA/CTM/Start-up) (HLAGAOAA)

Keywords

• IRB review services
• Clinical trial technology
• Site enablement solutions
• Institutional biosafety committee
• Clinical research services

Headquarters

HQ city

Puyallup

HQ country

United States

HQ region

North America

Offices2 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. IRB Review Services: Ethical review services for clinical trials including protocol review, informed consent review, and continuing review. Revenue generated through per-protocol fees and service contracts with pharmaceutical companies, biotech firms, and research institutions.
2. IBC Review Services: Institutional Biosafety Committee review services for human gene transfer research, gene therapy trials, and biologics studies. ISO 9001 certified service with dedicated workflow processes.
3. Technology Platform Subscriptions: SaaS subscriptions for ClinSphere platform including Total Enrollment, Total Feasibility, eReview Manager, and other integrated solutions. Annual or multi-year contract terms.
4. Endpoint Adjudication Committee Services: Independent adjudication services for clinical trial endpoints with hand-picked committees matched to optimize trials. 75+ FDA supported approvals and 150K+ events adjudicated.
5. Data Monitoring Committee Services: Independent DMC management and oversight services with hand-crafted committees, statistical analysis, and comprehensive reporting for trial safety monitoring.
6. Clinical Trial Training Services: Total Training solution providing live, virtual, hybrid, and on-demand clinical trial training with engagement analytics and compliance management.
7. Site Enablement Services: Coverage analysis, budget development, contract negotiation, CTMS build, and financial management services for research sites. Turnaround times of less than 5 days for key services.

Pricing tiers

Go-to-market motion3 records

Distribution channels6 records

Marketing channels9 records

Core offering

WCG IRB provides independent ethical review and clinical trial support services, including IRB and IBC (Institutional Biosafety Committee) protocol review for pharmaceutical, biotech, medical device, and gene therapy studies, delivered through the ClinSphere cloud platform. The company combines fee-based review and committee management services (DMC, Endpoint Adjudication, Statistical Consulting) with SaaS subscriptions for AI-powered trial design (Trial IntelX), recruitment (Total Enrollment), feasibility (Total Feasibility), and IRB workflow (eReview Manager). Its offerings also extend to site enablement via a network of 500+ research sites and 1,000+ investigators, plus KMR benchmarking, Total Training, and Avoca Quality Consortium membership.

Product overview

WCG Clinical (WCG IRB) operates as an integrated ecosystem of technology-enabled solutions organized around a central platform, WCG ClinSphere™, which powers AI-driven clinical trial intelligence and management. The product portfolio includes core platform products (ClinSphere Trial IntelX for AI-powered trial design, eReview Manager for IRB workflows, Total Enrollment and Total Feasibility for recruitment/site selection), CTMS solutions (eResearch Enterprise and eResearch eXpress), training platforms (Total Training, InvestigatorSpace with SafetyVigilance), and committee management tools (AIMS for adjudication, IRBNet, Connexus portal). These connect through ClinSphere to provide data intelligence across the clinical trial lifecycle. Beyond technology, WCG offers services including IRB Review, IBC Review, Data Monitoring Committees, Endpoint Adjudication, Statistical Consulting, Diversity/DEI solutions, Protocol Assessment, Quality Consortium membership, and Site Network enablement covering 500+ sites and 1,000+ investigators. The company recently announced acquisition of The Contract Network to add AI-powered contract and budget capabilities.

Differentiator

Problem solved

Functional benefit

Brands

• ClinSphere: Cloud platform bringing together WCG's applications, AI, and data intelligence for sites, sponsors, and CROs.
• eReview Manager
• InvestigatorSpace
• Total Enrollment
• Total Feasibility
• SafetyVigilance
• Total Training
• AIMS
• IRBNet
• eResearch Enterprise CTMS
• eResearch eXpress CTMS

Products and services

• WCG ClinSphere Integrated cloud platform that brings together WCG's applications, AI, and data intelligence to support clinical trial planning, execution, and oversight for sites, sponsors, and CROs.
• ClinSphere Trial IntelX AI-powered foresight product within ClinSphere that enables users to see trials before they start, transforming how trials are designed, planned, and delivered through predictive analytics on the industry's largest protocol dataset.
• eReview Manager Streamlined IRB workflow platform with real-time collaboration, intuitive workflows, reduced administrative burden, real-time reporting, and predictable turnaround times for IRB submissions and continuing review.
• ClinSphere Total Enrollment SaaS technology for streamlining participant recruitment and retention in clinical studies, providing centralized management and real-time visibility into enrollment performance.
• ClinSphere Total Feasibility Site feasibility solution optimizing study planning, site identification, and selection using clinical development insights, investigator match scores, and questionnaires that achieve a 60% response rate.
• Connexus Portal for IRB submissions and reviews providing full visibility into review status and timelines; serves as the entry point for IRB submissions during the transition to eReview Manager.
• InvestigatorSpace Comprehensive platform providing clinical trial training and safety letter acknowledgement with single-login access to training and safety records for investigators.
• AIMS Purpose-built platform for Endpoint Adjudication Committee management that streamlines member recruitment, training, communication, and invoicing for adjudication across global trials.
• IRBNet Protocol review and management system used by institutions for IRB submissions, tracking, and document management.
• eResearch Enterprise CTMS Fully configurable, customizable, and integrated Clinical Trial Management System for managing entire research portfolios from start-up through close-out for large organizations.
• eResearch eXpress CTMS Ready-to-use, pre-configured cloud-based SaaS Clinical Trial Management System for rapid deployment with streamlined workflows and fast return on investment for mid-sized organizations.
• Latitude Study start-up service management platform used to track service request statuses and access financial management reports for research sites.
• Clinical Trial Listing Service (CTLS) Service and platform that helps participants find clinical research studies matching their interests and needs.
• Total Training End-to-end clinical trial training solution unifying in-person, virtual, hybrid, and on-demand training with audience engagement tools and enhanced analytics; reported to reduce protocol deviations by 35-50%.
• Study Accelerator Connected, insight-driven solution combining site identification and feasibility, ethical review, and participant recruitment and retention to reduce study timelines by up to 20%.
• IRB Review Services Comprehensive independent IRB review services delivered by nearly 200 IRB experts with less than 6-day turnaround for new protocols and less than 2-day turnaround for new sites, available via IRB+ expedited service.
• IBC Review Services Institutional Biosafety Committee review services for human gene transfer research, gene therapy trials, and biologics studies; ISO 9001 certified with dedicated workflow processes.
• Data Monitoring Committee Services Independent Data Monitoring Committee management and oversight services with 1,200+ global experts across 75 therapeutic sub-specialties and 250 academic institutions, including statistical analysis and reporting.
• Endpoint Adjudication Committee Services Independent Endpoint Adjudication Committee services for assessment of safety and efficacy endpoints, with hand-picked expert committees supporting 75+ FDA approvals and 150K+ events adjudicated.
• Statistical Consulting Solutions Full-service statistical support from dedicated biostatisticians across clinical trial design, regulatory strategy, CDISC compliance, and analysis for sponsors and biotech firms.
• Avoca Quality Consortium Collaborative consortium of 200+ member companies providing 1,500+ tools, templates, leading practices, and metrics for quality and risk management across sponsors, CROs, and sites.
• Diversity, Equity, & Inclusion Solutions Solutions providing policies and processes to engage, educate, enroll, and retain diverse populations in clinical trials, including community advisory board methods and diversity planning.
• 360 Protocol Assessment Integrated protocol assessment solution providing operational risk and feasibility assessment from multi-functional stakeholder perspectives to ensure protocol quality by design.
• WCG Site Network Network of 500+ clinical research site locations and 1,000+ investigators available to sponsors and CROs for site identification and partnership, with 1,075+ studies placed in the last five years.
• Site Enablement Solutions Comprehensive solutions for research sites including study start-up, coverage analysis, budget development, contract review, CTMS build, and financial management with less than 5-day turnaround.
• Study Start-Up Services Coverage analysis, budget, contract, and CTMS study build services for research sites with less than 5-day turnaround for core services and 40-60% reduction in budget and contract negotiation timelines.
• Financial Management Services Billing and accounts receivable management services with a financial management tracking portal for research sites.
• KMR Benchmarking Web-based benchmarking solutions providing clinical trial cycle time, enrollment, and cost metrics from a database of 38,000+ clinical trials and 1 million+ site records spanning 400+ rare diseases and 120+ countries.
• Safety Letter Distribution Enterprise safety letter distribution service supporting 250+ countries with 30,000+ daily safety letters distributed as part of clinical trial safety reporting.

Quantifiable outcome

• 94% of FDA-approved therapeutic agents in the last five years supported by WCG
• +10 more outcomes

Named customers10 records

Segments8 records

Ideal customer profiles6 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability7 records

Feature8 records

Partnerships

Five partnerships are on record, tiered core and strategic.

• The Contract NetworkcoreStrategic or Co-development Partner · 21 April 2026WCG announced intent to acquire The Contract Network to strengthen site enablement capabilities with AI-powered contract and budget solutions. This acquisition will enhance WCG's comprehensive site enablement suite.
• MRCT CentercoreStrategic or Co-development Partner · 26 June 2024First multi-stakeholder consortium co-led with MRCT Center to address ethical challenges in AI-based clinical research. Joint task force to develop guidance for ethical oversight of AI in clinical trials.
• Florence HealthcarestrategicTechnology or Integration · 13 November 2023Partnership to advance site enablement in clinical research through technology integration, connecting site operations with WCG's comprehensive service suite.
• MerckstrategicStrategic or Co-development PartnerStrategic partnership featuring webinars and thought leadership on unblocking bottlenecks and empowering research sites. Partnership addresses clinical trial efficiency challenges.
• Dr. Vince Clinical ResearchstrategicStrategic or Co-development PartnerPartnership to expand Phase I review services. WCG IRB expanded Phase I review capabilities through partnership with Dr. Vince Clinical Research.

Scale indicators15 records

Recent moves6 records

Expansion highlights7 records

Direct peers

• Advarra: Advarra is the other leading central IRB in the U.S., providing IRB review, IBC services, and research compliance technology for clinical trials. It is the closest direct competitor to WCG IRB, serving the same sponsor, CRO, and academic site customer base with overlapping review and ethics services.

Broad incumbents

• IQVIA: IQVIA is the world's largest CRO with broad clinical operations, technology, and site enablement capabilities. While not a pure IRB provider, IQVIA's scale, R&D technology platform, and bundled offerings overlap with WCG's ClinSphere-enabled site and sponsor services.
• ICON plc: ICON is a top global CRO offering clinical operations, site activation, and technology platforms across the trial lifecycle. It competes with WCG for sponsor and CRO outsourcing spend, particularly on integrated study start-up and site enablement engagements.
• Labcorp Drug Development: Labcorp (formerly Covance/Fortrea) provides central laboratory, clinical development, and site enablement services. Its broad portfolio overlaps with WCG's site enablement, biomarker, and clinical operations offerings for biopharma sponsors.
• Parexel: Parexel is a major global CRO delivering clinical trial operations, regulatory, and biostatistics services. It is comparable to WCG as an enterprise services provider to pharma and biotech sponsors across the clinical development lifecycle.
• Medpace: Medpace is a mid-to-large CRO with full-service clinical development offerings. While not IRB-focused, it competes with WCG for sponsor study planning, feasibility, and site activation work.
• Syneos Health: Syneos Health is a clinical and commercial solutions provider for biopharma, combining CRO services with site and patient activation capabilities. It competes with WCG for sponsor site enablement and study start-up engagements.
• Charles River Laboratories: Charles River offers research models, discovery, safety assessment, and manufacturing services alongside clinical support. Its clinical and safety services overlap with parts of WCG's clinical trial support portfolio, particularly for early-phase and safety-monitored programs.

Emerging players

• Clario (formerly ERT): Clario provides clinical trial technology, including eCOA, imaging, and endpoint data solutions. It is comparable as a technology-enabled clinical trial services peer with adjacent endpoint and patient data capabilities to WCG's AIMS and ClinSphere offerings.
• Florence Healthcare: Florence Healthcare is a site enablement technology company with an electronic Investigator Site File (eISF) platform, and a formal WCG partner. It is comparable as a site-focused clinical research technology peer adjacent to WCG's site enablement portfolio.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks5 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/wcg-clinical

Compliance3 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles4 records

Subsidiaries5 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about WCG IRB